Drug Loading Articles & Analysis
16 news found
CD Formulation, a leading pharmaceutical contract service company, has recently unveiled groundbreaking hydrogel microneedle patch technology aiming at increase the drug loading capacity and enhance drug delivery efficiency. The new technology represents a significant advancement in the field of transdermal drug delivery. The ...
CD Bioparticles is committed to easing the burden on its customers by reducing cumbersome chemical synthesis, formulation and purification, improving drug loading efficiency and yield of drug delivery materials, and helping customers track and image the distribution of polymer-based (nano)materials to avoid strong immunoreactivity or xenobiotic ...
CD Formulation's cutting-edge research and development team has successfully created micro-reservoir systems that offer precise drug release kinetics. By manipulating key factors such as reservoir size, drug loading, and polymer selection, the team has achieved remarkable control over drug release rates. ...
CD Formulation understands the critical importance of selecting the right excipients, polymer matrices, and drug loading techniques to ensure optimal drug stability and release. Its team of experienced scientists collaborates closely with clients to design customized formulations based on their specific drug molecules and ...
This testing process is designed to analyze the formulation and structural characteristics of microneedles, allowing manufacturers to optimize their design and ultimately enhance drug delivery effectiveness. To evaluate the drug delivery performance, CD Formulation performs extensive drug loading and homogeneity testing on ...
By leveraging cutting-edge conjugation methods, targeting drug delivery solutions, and RNAi delivery systems, scientists can gain unprecedented control over the design and synthesis of bioconjugates. ...
With customized delivery strategies, precise design and transformation of drugs/drug-loaded cargos, and advanced technology platforms, CD Bioparticles now offers a series of mRNA Transfection Reagents for researchers to assist the transfection of lipid vectors for mRNA into target cells. ...
The top priority for drug delivery research is to develop novel materials or carrier systems to achieve more effective therapeutic delivery of drugs. ...
The rapidly dissolving yarn is a key element in the innovative EsoCap system which enables local placement of drug-loaded films and targeted, long-lasting drug delivery in the esophagus (Rosenbaum et al., Pharmaceutics 2022, 14, 1229). ...
Customers can find desirable biodegradable polymers at CD Bioparticles to solve challenges like tedious chemical synthesis and purifications, limited options for the bio-conjugation between macromolecules and biomolecules, unpredictable or uncontrollable degradation rate of the drug-loading cargo, and uncontrollable drug delivery profile. For ...
CD Bioparticles, a leading manufacturer and supplier of various drug delivery products and services, now introduces a series of Heparins products to support drug delivery research, such as the Heparin Biotin, Heparin Amine, and Heparin Thiol. ...
![[IB Tomato] (VC Portfolio) Villix, Containing the Identity of Reverse Idea and Novelty](/_ipx/q_80&s_240x145/https://d32zuqhgcrpxli.cloudfront.net/eyJidWNrZXQiOiJlZS1maWxlcyIsImtleSI6ImZpbGVzLzEyNTE1Ni9pbWFnZXMvMTI1MTU2XzBfMjAyMzAyMTUxMTQwMjgzNDM5NDg4XzQwMC5QTkciLCJlZGl0cyI6eyJyZXNpemUiOnsiZml0IjoiY29udGFpbiIsImJhY2tncm91bmQiOnsiciI6MjU1LCJnIjoyNTUsImIiOjI1NSwiYWxwaGEiOjF9LCJ3aWR0aCI6MjQwLCJoZWlnaHQiOjE0NX19fQ== "[IB Tomato] (VC Portfolio) Villix, Containing the Identity of Reverse Idea and Novelty")
If you leave the empty part of the inner circle as it is, it becomes an anti-inflammatory treatment by itself, so if you put an anticancer drug in the empty space, it wraps around the anticancer drug without causing any chemical reaction. CEO Kim Myung-lip said, “When an anticancer drug is loaded into the ball, the ...
The claims cover a proprietary method of loading exosomes with nucleic acids via binding to nucleic acid binding proteins PUF, Cas6, Cas13 or a nucleic acid aptamer binding protein, and they reinforce the Company’s leading position within field of exosome therapeutics. ...
Interest in bilirubin is high worldwide. This is because bilirubin has already received attention as a substance that has strong antioxidant effects and immunomodulatory effects through 30,000 papers from several decades ago. However, there were clear limitations in developing it as a new drug. This is because it is extremely hydrophobic, insoluble in water. It is Bilix that solved this problem. ...
Although it has been attracting attention as a drug, it is because of its 'extremely hydrophobic' (characteristic of not being soluble in water). ...
Additionally, these organic materials have the potential to load different drugs, including chemotherapeutic agents, for transarterial chemoembolization (TACE) procedures. ...